C. Mehle

发表

A non-random deletion in the p53 gene in oral squamous cell carcinoma.

M. Eriksson, M. Eriksson, K. Nylander, 1996, British Journal of Cancer.

Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse

R. Rosenquist, G. Roos, J. Lindh, 2000, British Journal of Cancer.

DNA fingerprinting of renal cell carcinoma with special reference to tumor heterogeneity

G. Roos, R. Stenling, B. Ljungberg, 1993, Genes, chromosomes & cancer.

Telomerase activity in human renal cell carcinoma.

J. Shay, G. Roos, B. Ljungberg, 1996, Oncogene.

Telomerase activity in vivo in human malignant hematopoietic cells.

G. Roos, P. Nilsson, K. Remes, 1994, Oncogene.

p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.

K. Nylander, G. Roos, P. Nilsson, 1995, British Journal of Cancer.

Telomere shortening in renal cell carcinoma.

G. Roos, B. Ljungberg, C. Mehle, 1994, Cancer research.

Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.

G. Roos, R. Stenling, B. Ljungberg, 1996, British Journal of Cancer.

MeningiSSS: A New Predictive Score to Support Decision on Invasive Procedures to Monitor or Manage the Intracerebral Pressure in Children with Bacterial Meningitis

S. Silfverdal, C. Mehle, L. Karlsson, 2019, Neurocritical Care.

Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma.

A. Lindblom, G. Roos, R. Stenling, 1998, International journal of oncology.

Clinical significance of nm23 expression in renal cell carcinoma

B. Ljungberg, C. Mehle, B. Österdahl, 1999, Urological Research.